Last updated: June 20, 2025
Sponsor: Azienda USL Reggio Emilia - IRCCS
Overall Status: Completed
Phase
N/A
Condition
Breast Cancer
Cancer
Treatment
Continuous serratus plane block
Clinical Study ID
NCT03992859
CIMPAX BREAST
Ages 18-80 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
age > 18
breast surgery
informed consent
Exclusion
Exclusion Criteria:
ASA >3
allergy to local anesthetic
opioid administration in the last month
patient refusal
Study Design
Total Participants: 15
Treatment Group(s): 1
Primary Treatment: Continuous serratus plane block
Phase:
Study Start date:
January 12, 2018
Estimated Completion Date:
December 30, 2021
Study Description
Connect with a study center
Ausl-Irccs Reggio Emilia
Reggio Emilia, RE 42120
ItalySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.